Description
Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02016-11-01$109,216
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2016-11-01(start date) | $109,216 | — | Immuno-modulatory HIV-1 nanoparticles as a novel vaccine platform |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2026-2027-Q1-01080 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,017,450 | FY2027 |
| 236-2020-2021-Q1-00030 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $870,768 | FY2021 |
| 236-2019-2020-Q4-00253 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $110,430 | FY2020 |
| 236-2017-2018-Q3-00091 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $500,000 | FY2018 |
| 236-2016-2017-Q2-00708 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $947,980 | FY2017 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q3-00029 · retrieved 2026-11-14.